These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 18541523

  • 1. Post-infarct treatment with an erythropoietin-gelatin hydrogel drug delivery system for cardiac repair.
    Kobayashi H, Minatoguchi S, Yasuda S, Bao N, Kawamura I, Iwasa M, Yamaki T, Sumi S, Misao Y, Ushikoshi H, Nishigaki K, Takemura G, Fujiwara T, Tabata Y, Fujiwara H.
    Cardiovasc Res; 2008 Sep 01; 79(4):611-20. PubMed ID: 18541523
    [Abstract] [Full Text] [Related]

  • 2. Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis.
    Kobayashi H, Yasuda S, Bao N, Iwasa M, Kawamura I, Yamada Y, Yamaki T, Sumi S, Ushikoshi H, Nishigaki K, Takemura G, Fujiwara T, Fujiwara H, Minatoguchi S.
    J Cardiovasc Pharmacol; 2009 Dec 01; 54(6):510-9. PubMed ID: 19755919
    [Abstract] [Full Text] [Related]

  • 3. Erythropoietin in cardioprotection: does it have a future or is it all in the past?
    Mehta JL.
    Cardiovasc Res; 2008 Sep 01; 79(4):549-50. PubMed ID: 18583337
    [No Abstract] [Full Text] [Related]

  • 4. Complementary therapeutic effects of dual delivery of insulin-like growth factor-1 and vascular endothelial growth factor by gelatin microspheres in experimental heart failure.
    Cittadini A, Monti MG, Petrillo V, Esposito G, Imparato G, Luciani A, Urciuolo F, Bobbio E, Natale CF, Saccà L, Netti PA.
    Eur J Heart Fail; 2011 Dec 01; 13(12):1264-74. PubMed ID: 22045926
    [Abstract] [Full Text] [Related]

  • 5. Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival.
    Zaruba MM, Huber BC, Brunner S, Deindl E, David R, Fischer R, Assmann G, Herbach N, Grundmann S, Wanke R, Mueller-Hoecker J, Franz WM.
    Cardiovasc Res; 2008 Mar 01; 77(4):722-31. PubMed ID: 18055578
    [Abstract] [Full Text] [Related]

  • 6. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure.
    Li Y, Takemura G, Okada H, Miyata S, Maruyama R, Li L, Higuchi M, Minatoguchi S, Fujiwara T, Fujiwara H.
    Cardiovasc Res; 2006 Sep 01; 71(4):684-94. PubMed ID: 16828072
    [Abstract] [Full Text] [Related]

  • 7. Alteration in erythropoietin-induced cardioprotective signaling by postinfarct ventricular remodeling.
    Miki T, Miura T, Yano T, Takahashi A, Sakamoto J, Tanno M, Kobayashi H, Ikeda Y, Nishihara M, Naitoh K, Ohori K, Shimamoto K.
    J Pharmacol Exp Ther; 2006 Apr 01; 317(1):68-75. PubMed ID: 16377761
    [Abstract] [Full Text] [Related]

  • 8. Postinfarct active cardiac-targeted delivery of erythropoietin by liposomes with sialyl Lewis X repairs infarcted myocardium in rabbits.
    Yamada Y, Kobayashi H, Iwasa M, Sumi S, Ushikoshi H, Aoyama T, Nishigaki K, Takemura G, Fujiwara T, Fujiwara H, Kiso M, Minatoguchi S.
    Am J Physiol Heart Circ Physiol; 2013 Apr 15; 304(8):H1124-33. PubMed ID: 23417861
    [Abstract] [Full Text] [Related]

  • 9. Single high-dose intramyocardial administration of erythropoietin promotes early intracardiac proliferation, proves safety and restores cardiac performance after myocardial infarction in rats.
    Gäbel R, Klopsch C, Furlani D, Yerebakan C, Li W, Ugurlucan M, Ma N, Steinhoff G.
    Interact Cardiovasc Thorac Surg; 2009 Jul 15; 9(1):20-5; discussion 25. PubMed ID: 19380336
    [Abstract] [Full Text] [Related]

  • 10. Impairment of cardioprotective PI3K-Akt signaling by post-infarct ventricular remodeling is compensated by an ERK-mediated pathway.
    Miki T, Miura T, Tanno M, Nishihara M, Naitoh K, Sato T, Takahashi A, Shimamoto K.
    Basic Res Cardiol; 2007 Mar 15; 102(2):163-70. PubMed ID: 16944359
    [Abstract] [Full Text] [Related]

  • 11. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis.
    Wang Y, Ahmad N, Wani MA, Ashraf M.
    J Mol Cell Cardiol; 2004 Nov 15; 37(5):1041-52. PubMed ID: 15522281
    [Abstract] [Full Text] [Related]

  • 12. Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats.
    Xu X, Wan W, Ji L, Lao S, Powers AS, Zhao W, Erikson JM, Zhang JQ.
    Cardiovasc Res; 2008 Jun 01; 78(3):523-32. PubMed ID: 18252761
    [Abstract] [Full Text] [Related]

  • 13. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment.
    Minatoguchi S, Takemura G, Chen XH, Wang N, Uno Y, Koda M, Arai M, Misao Y, Lu C, Suzuki K, Goto K, Komada A, Takahashi T, Kosai K, Fujiwara T, Fujiwara H.
    Circulation; 2004 Jun 01; 109(21):2572-80. PubMed ID: 15123535
    [Abstract] [Full Text] [Related]

  • 14. Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling.
    Yarbrough WM, Mukherjee R, Escobar GP, Mingoia JT, Sample JA, Hendrick JW, Dowdy KB, McLean JE, Lowry AS, O'Neill TP, Spinale FG.
    Circulation; 2003 Oct 07; 108(14):1753-9. PubMed ID: 12975256
    [Abstract] [Full Text] [Related]

  • 15. Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.
    Fraccarollo D, Widder JD, Galuppo P, Thum T, Tsikas D, Hoffmann M, Ruetten H, Ertl G, Bauersachs J.
    Circulation; 2008 Aug 19; 118(8):818-27. PubMed ID: 18678774
    [Abstract] [Full Text] [Related]

  • 16. Effects of basic fibroblast growth factor microspheres on angiogenesis in ischemic myocardium and cardiac function: analysis with dobutamine cardiovascular magnetic resonance tagging.
    Liu Y, Sun L, Huan Y, Zhao H, Deng J.
    Eur J Cardiothorac Surg; 2006 Jul 19; 30(1):103-7. PubMed ID: 16730451
    [Abstract] [Full Text] [Related]

  • 17. The inhibition of postinfarct ventricle remodeling without polycythaemia following local sustained intramyocardial delivery of erythropoietin within a supramolecular hydrogel.
    Wang T, Jiang XJ, Lin T, Ren S, Li XY, Zhang XZ, Tang QZ.
    Biomaterials; 2009 Sep 19; 30(25):4161-7. PubMed ID: 19539990
    [Abstract] [Full Text] [Related]

  • 18. Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats.
    Azizi Y, Faghihi M, Imani A, Roghani M, Zekri A, Mobasheri MB, Rastgar T, Moghimian M.
    Eur J Pharmacol; 2015 Aug 15; 761():101-8. PubMed ID: 25936512
    [Abstract] [Full Text] [Related]

  • 19. Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties.
    Copland IB, Jolicoeur EM, Gillis MA, Cuerquis J, Eliopoulos N, Annabi B, Calderone A, Tanguay JF, Ducharme A, Galipeau J.
    Cardiovasc Res; 2008 Aug 01; 79(3):405-15. PubMed ID: 18397963
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone attenuates myocardial fibrosis in rats with chronic pressure overload-induced left ventricular hypertrophy.
    Moreira VO, Pereira CA, Silva MO, Felisbino SL, Cicogna AC, Okoshi K, Aragon FF, Padovani CR, Okoshi MP, Castro AV.
    Clin Exp Pharmacol Physiol; 2009 Mar 01; 36(3):325-30. PubMed ID: 19278522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.